Abstract
Glycated hemoglobin (HbA1c) is commonly used to assess long-term glycemic control in patients with diabetes mellitus. Numerous conditions, including hemoglobinopathies, can alter HbA1c measurements and cause misleading results. More than 20 methods for determining HbA1c are commercially available to clinical laboratories. Herein, we report a diabetic patient in whom the HbS variant was detected on the basis of discrepant Hb1Ac levels estimated using immunonephelometry or high-performance liquid chromatography (HPLC). The patient, a 48-year-old African man with a 10-year history of type 2 diabetes, was referred to our hospital with an HbA1c level estimated at 13.3 % by immunonephelometry and 7.6 % by HPLC, whereas the glycoalbumin level was 47.5 %. These discrepancies prompted us to carry out genetic sequence analysis in which we identified an A → T transversion in codon 6 of the patient’s HBB gene, corresponding to a predicted E6V substitution (βCD6) characteristic of HbS. Our results indicate that redundant measurements of HbA1c using diverse methods may be useful when the presence of abnormal Hb is suspected.
Similar content being viewed by others
References
Koga M, Suzuki MK, Tanahashi Y. Calculation of HbA1c and glycated albumin from serially measured self-monitored blood glucose in patients with type 1 diabetes mellitus. Clin Chim Acta. 2013;425:188–91.
John G, English E. IFCC standardized HbA(1c): should we be as one? Clin Chem Lab Med. 2012;50:1243–8.
Rhea JM, Molinaro R. Pathology consultation on HbA1c methods and interferences. Am J Clin Pathol. 2014;141:5–16.
Behan KJ, Merschen J. HbA1c does not always estimate average glucose. Clin Lab Sci. 2011;24:71–7.
Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol. 2009;3:446–51.
Friss U, Beck A, Kohne E, Lehmann R, Koch S, Haring HU, Schmuelling RM, Schleicer E. Novel hemoglobin vaiant[beta(E10)Lys → Asn], with decreased oxygen affinity, causes falsely low hemoglobin A1c values by HPLC. Clin Chem. 2003;49:1412–5.
Castelli R, Tempesta A, Bianchi A, Porro T, Ivaldi G, Cappellini MD. Unreliable estimation of HbA due to the presence of Camperdown haemoglobin [beta 104 (G6) Arg → Ser]. Diabet Med. 2004;21:377–9.
Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153–63.
Watanabe N. Inspection item useful as an index of blood glucose control-purposes and cautions of inspection. Med Technol. 2013;41:153–64 (in Japanese).
Jaina N, Kesimer M, Hoyer JD, Calikoglu AS. Hemoglobin Raleigh results in factitiously low hemoglobin A1c when evaluated via immunoassay analyzer. J Diabetes Complicat. 2011;25:14–8.
Kluger R. Red cell substitutes from hemoglobin-do we start all over again? Curr Opin Chem Biol. 2010;14:538–43.
Yamashiro Y. Identification of hemoglobin variants. Med Technol. 2004;32:565–72 (in Japanese).
Masiello D, Heeney MM, Adewoye AH, Eung SH, Luo HY, Steinberg MH, Chui DH. Hemoglobin SE disease-A concise review. Am J Hematol. 2007;82:643–9.
Lippi G, Mercadanti M, Alberta C, Franchini M. An unusual case of a spurious, transfusion-acquired haemoglobin S. Blood Transfus. 2010;8:199–202.
Harano T. Hemoglobinopathy in Japan: detection and analysis. Rinsho Byori. 1999;47:215–23 (in Japanese).
McCurdy PR. 32-DFP and 51-Cr for measurement of red cell life span in abnormal hemoglobin syndromes. Blood. 1969;33:214–24.
Takarabe D, Kishimoto M, Tanaka T, Takahashi Y, Kajio H, Harano K, Noda M. Hemoglobin variant HbE found in two south Asian diabetic patients. Intern Med. 2009;48:1397–401.
Sacks DB. Hemoglobin variants and hemoglobin A1c analysis: problem solved? Clin Chem. 2003;49:1245–12457.
Rhea JM, Koch D, Ritchie J, Singh HV, Young AN, Burgess T, Molinaro RJ. Unintended reporting of misleading HbA(1c) values when using assays incapable of detecting hemoglobin variants. Arch Pathol Lab Med. 2013;137:1788–91.
Reeve J, Blake L, Griffin D, O’Shea P. Incidental detection of hemoglobin (Hb) variants during high performance liquid chromatography (HPLC) analysis of HbA1c: is it time for a standardized approach to reporting? Ir J Med Sci. 2015;184:353–5.
Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobin varoants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Rev. 2001;17:94–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human Rights Statement and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki, 1964, and later versions. Informed consent was obtained for being included in the study.
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Yusuke Takeda and Daiji Kawanami have equally contributed to this work.
About this article
Cite this article
Takeda, Y., Kawanami, D. & Utsunomiya, K. Detection of hemoglobin variant HbS on the basis of discrepant HbA1c values in different measurement methods. Diabetol Int 7, 199–203 (2016). https://doi.org/10.1007/s13340-015-0237-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13340-015-0237-8